Viemed Healthcare Inc (VMD) financials
Viemed Healthcare revenue and earnings by year
Viemed Healthcare's revenue was $270 million in the fiscal year to December 31, 2025, up 20.5% from the year before. Net income was $14.9 million, 5.5% of revenue. Since the fiscal year to December 31, 2017, revenue has grown 24.5% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 9 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 270 | 224 | 183 | 139 | 117 | 131 | 80 | 64 | 47 |
| Revenue growth | 20.5% | 22.5% | 31.8% | 18.6% | -10.8% | 63.6% | 24.5% | 37.4% | — |
| Gross profit | 155 | 133 | 113 | 85 | 73 | 80 | 56 | 48 | 35 |
| Gross margin | 57.5% | 59.4% | 61.6% | 61.0% | 62.7% | 61.0% | 69.8% | 74.1% | 73.8% |
| Operating income | 23 | 18 | 14 | 8 | 12 | 27 | 9 | 10 | 9 |
| Operating margin | 8.5% | 8.0% | 7.8% | 5.9% | 9.9% | 20.4% | 11.5% | 15.6% | 18.4% |
| Net income | 15 | 11 | 10 | 6 | 9 | 32 | 9 | 10 | 8 |
| Net margin | 5.5% | 5.0% | 5.6% | 4.5% | 7.8% | 24.0% | 10.6% | 14.7% | 17.4% |
| Diluted EPS | $0.37 | $0.28 | $0.25 | $0.16 | $0.22 | $0.78 | $0.21 | $0.24 | — |
| Free cash flow | 28 | 12 | 22 | 6 | 3 | 27 | 6 | 17 | 8 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open VMD in Markets.
See also: VMD valuation and P/E history · VMD returns
No forecast, no recommendation. This page describes Viemed Healthcare Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.